A new collagen revolution continues to sweep across China. How does the national brand Kefumei take the lead?

On April 17, 2021, the joint press conference of Juzi Bio, the first company to settle in the Science and Technology Innovation and Transformation Base of the National Clinical Research Center for Skin and Immunological Diseases, was successfully held. Authoritative experts in the dermatology field, leaders in the scientific research field, professional opinion leaders in skin care, mainstream media, etc. gathered in Beijing to witness this cutting-edge, forward-looking, creative and flagship event.

On April 17, 2021, the joint press conference of Juzi Bio, the first company to settle in the Science and Technology Innovation and Transformation Base of the National Clinical Research Center for Skin and Immunological Diseases, was successfully held. Authoritative experts in the dermatology field, leaders in the scientific research field, professional opinion leaders in skin care, mainstream media, etc. gathered in Beijing to witness this cutting-edge, forward-looking, creative and flagship event. Juzi Bio's star brands, represented by Kefumei, have won wide acclaim from consumers for their professional strength in skin repair in recent years. As a "new domestic dark horse", it still attracted much attention at this scientific research event.

The press conference specially invited representatives from the field of dermatology and scientific research, Professor Li Hang from Peking University First Hospital, Professor Fan Daidi, founder of Human-like® recombinant collagen, corporate representatives, Xin Zhen, senior operations expert in the medical device industry of Tmall Ali Health, Yan Jianya, chairman of Juzi Biotechnology, and opinion leaders, including Tsinghua Skin Care Senior Wang Zhi, K University, Basic Beauty Research, and Exquisite Uncle, to attend the press conference. It has attracted the attention of professional skin care media such as Meili Xiuxing, Jumei, China Cosmetics News, Qingyan, and Beauty Industry Observation, as well as mainstream media such as 36Kr, People's Daily Overseas Edition, People's Daily Digital, Ebrun Power Network, Consumer Daily, International Online, Outlook News Weekly, and Banyuetan. This is another major industry feat of Juzi Bio in the field of dermatology and aesthetics after the establishment of Juzi Dermatology Research Institute in 2019 and the launch of the "Expert Consensus on the Application of Human Collagen in Dermatology and Aesthetics" in 2020.

Reorganization of industry, academia, research and medicine

Build an industry-university-research-medicine "ecosystem" to leverage the "new vitality" of national enterprises

Witnessed by authoritative experts and mainstream media, the joint launch ceremony of Juzi Biotechnology, the first company to settle in the Scientific Innovation and Transformation Base of the National Clinical Research Center for Skin and Immunological Diseases, was successfully held, ushering in a groundbreaking move of deep integration and collaborative innovation of "industry, academia, research and medicine" in the field of dermatological and aesthetic medicine.

Juzi Bio and the National Clinical Research Center for Skin and Immunological Diseases based at Peking University First Hospital are conducting joint research on the mechanism of action and clinical application of Human-like® recombinant collagen in the field of dermatology and cosmetology. The first issue of the project "Study on the Functional Effects of Human-like® Recombinant Collagen on Fibroblasts and Melanocytes" was also released.

In the future, the two parties will pool resources from various fields, use industry to lead the transformation of scientific research results, use laboratory research and development to drive the development of the science and technology industry, and ultimately achieve a four-in-one full industry chain closed loop of "exploring the mechanisms of skin problems - research and development and creation of core ingredients and technologies - clinical verification of safety and effectiveness - promotion and application of products." Systematize academic research, industrialize scientific research results, and implement medical applications to benefit consumers.

Two-way empowerment and collaborative innovation

Cutting-edge medical research and innovation "strong combination" empowers domestic brands to "strengthen their strength"

After nearly a year of investigation, inspection and research by the National Clinical Research Center for Skin and Immunological Diseases, Juzi Biopharma became the first company to settle in the Scientific Innovation and Transformation Base of the National Clinical Research Center for Skin and Immunological Diseases.

As one of the main initiators of this federation, the National Clinical Research Center for Skin and Immunological Diseases is a research center built based on Peking University First Hospital. The center's work aims at clinical application, conducts basic and clinical research related to skin and immune diseases, highlights the transformation and application of innovative results in the field of dermatology, promotes the continuous improvement of the diagnosis and treatment of skin diseases, and contributes to the quality improvement of the diagnosis and treatment of skin and immune diseases across the country.

Juzi Bio's human-like collagen technology has won a number of national funds and development support, including the National Natural Science Foundation, the "Technology Innovation Fund for Science and Technology-based Small and Medium-sized Enterprises" of the Ministry of Science and Technology, the "Torch Program" of the Ministry of Science and Technology, and the "863 Program" of the Ministry of Science and Technology. At present, it has applied for more than 80 invention patents and won the National Technological Invention Award and the China Patent Gold Award. Its star brands, including Kefumei®, Kelijin®, Kepre®, Kehen®, Kelijin Starlight® and Kefuping®, have entered the dermatology and laser departments of more than 3,500 public hospitals and private medical beauty institutions, serving the public together with more than 3,000 professional dermatologists, and have won high praise from many authoritative experts in the field of dermatology.

Professor Li Hang said: "The entry of Juzi Bio means that both parties will carry out scientific and technological innovation and research in the field of dermatology around the skin health issues of Chinese people, break the traditional model of current clinical medical research, build a clinical practice scientific research innovation platform, and promote the real development of cutting-edge medical technology. The two parties will join hands with national scientific and technological experts, dermatologists and talents from all walks of life to explore a long-term cooperation mechanism between industry, academia, research and medicine, which is a big step for Chinese science and technology and national brands!"

Good news for the technology sector

The "new revolution" of recombinant collagen technology creates a "new era" in the industry

At the press conference, Professor Fan Daidi, Dean of the Institute of Biomedicine of Northwestern University, Chief Scientist of Juzi Biotechnology, and inventor of Human-like® recombinant collagen, deeply analyzed the future development trend of the collagen industry and announced the breakthrough technological progress of Human-like® recombinant collagen of Juzi Biotechnology, which created a new era in China's scientific and technological innovation and collagen fields!

Professor Fan Daidi pointed out: "In 2021, Juzi Bio's patented human-like collagen technology will be upgraded to a patented human-like recombinant collagen bionic combination technology. The upgraded combination specifically includes (1) recombinant type I human collagen; (2) recombinant type III human collagen; (3) recombinant human-like® collagen; (4) mini small molecule recombinant collagen peptides. We will combine the above four different recombinant collagens in different bionic combinations and add them to a series of products such as cosmetics, medical devices, and health care products at different concentrations to meet the diverse efficacy demands and play a greater role in anti-aging, repair and other fields!"

This is the most advanced and groundbreaking technological innovation in the field of recombinant collagen in China and internationally, and it caused a sensation in the industry. Juzi Bio is also the first national recipient of a recombinant collagen patent, the first holder of a recombinant collagen medical device certificate, the first producer of recombinant collagen that has been clinically proven to be in full contact with blood, the unit with the most research papers and R&D categories in the field of recombinant collagen at home and abroad, the first recipient of the National Technological Invention Award for recombinant collagen, and the first holder of the China Patent Gold Award for recombinant collagen. Professor Fan Daidi said: "As a leader in the field of recombinant collagen, Juzi Bio will shoulder the social responsibility of guiding the standardized development of the recombinant collagen market and promoting the widespread application of recombinant collagen in the field of skin medical beauty. In the future, we will work with the National Clinical Research Center for Skin and Immune Diseases to continuously increase research investment in new products, and continue to promote the transformation and implementation of new scientific research results in product upgrades, quality advancement, and technological innovation to protect the skin health of the Chinese people!"

Comix is ​​a star brand of Juzi Biotechnology that focuses on functional problem skin repair. It carries Juzi Biotechnology's latest research results and highest technical level in the field of recombinant collagen over the past 20 years. At the same time, as a well-known veteran brand in the field of dermatology and beauty, its offline market has covered hundreds of cities across the country, and has settled in more than 3,500 hospitals and medical institutions, serving the public together with more than 3,000 professional doctors. It has won high praise from many authoritative experts in the field of dermatology and has witnessed the skin changes of countless consumers.

Beautiful China Summit Forum

Responding to the Healthy China "Grand Strategy" and Creating a Beautiful China "New Era"

The "Industry-University-Research-Medical, Assisting the Transformation of Scientific Research Results" forum attended by Professor Li Hang from Peking University First Hospital, Xin Zhen, a senior operations expert in the medical device industry of Tmall Ali Health, Professor Fan Daidi, the inventor of Human-like® recombinant collagen, and Chairman Yan Jianya of Juzi Biotechnology was a highlight of this press conference.

The outline of the "14th Five-Year Plan" released this year clearly pointed out the need to "launch a Chinese brand creation campaign." Protect and develop time-honored Chinese brands, enhance the influence and competitiveness of independent brands, and take the lead in cultivating China's "high-end brands" in the fields of cosmetics, clothing, etc. This is a new opportunity for scientific research and technology, as well as a new opportunity for Chinese national enterprises. With the continuous enhancement of the country's economic strength and the upgrading of people's consumption demands for health and beauty, building a full chain of "industry, academia, research and medicine" and driving the high-quality development of national enterprises with scientific and technological innovation is an important step in leading the "national health".

Protect health and transfer energy

Caring for the "big health" of people's skin and practicing the social responsibility of "love energy"

Juzi Bio has always taken "protecting the skin health of the Chinese people" as its mission, guiding the Chinese people to pay attention to skin health and leading the whole nation in scientific skin care. The launch of the “Searching for the Most Beautiful Smile” public welfare project can be regarded as the highlight of this press conference.

The project is based on the premise of "paying attention to the skin health of the people and advocating scientific skin care concepts". It takes the lead in carrying out public welfare activities such as consultation, donation, and assistance to target the skin problems of five representative groups: doctors, children in mountainous areas, border guards, scientific researchers, and teachers. It provides comprehensive solutions and conveys the brand's dual care for consumers' skin and psychology.

Technology is heading to the US

Based on the "new momentum" of industry, academia, research and medicine, we will help Chinese brands "rise again"

The National Clinical Research Center for Skin and Immune Diseases has joined hands with Juzi Bio, the first national enterprise to settle in the center, to provide two-way empowerment. For national enterprises, domestic brands can finally break through the current technological barriers, starting from the core technologies that drive healthy growth of the enterprise, empower national brands with "innovation activities + hard-core strength", comprehensively drive the transformation and upgrading of the industry, benefit the skin health of the Chinese people, and truly realize the highlight moment of domestic brands catching up and counterattacking.

Originated from Juzi Biotechnology, a leader in recombinant collagen, its series of brands represented by Kefumei have been committed to in-depth research on the skin care needs of Chinese people with problematic skin. The scientific research team headed by Professor Fan Daidi has been tirelessly engaged in the research and development of recombinant collagen, insisting on using scientific research strength to support product strength and bring strong domestic products to consumers.

This strong alliance is of extraordinary significance and will also push Juzi Bio to the center of China's high-tech skin care industry. We shape the professional status of the industry through diversified scientific research results, and continuously enhance the social influence of the enterprise through hard-core product reputation and innovative scientific research exploration.

In response to the call of "Healthy China, Beautiful China", leading the scientific and standardized development of the industry, supporting the cause of "National Health", and promoting the arrival of the "Beautiful Era", both parties will rely on their strong scientific research strength to allow domestic brands to occupy the minds of consumers and step onto the international stage, constantly creating new miracles in inheritance, exploration, and change!